Lendvai, Gábor http://orcid.org/0000-0002-0931-380X
Szekerczés, Tímea
Kontsek, Endre
Selvam, Arun
Szakos, Attila
Schaff, Zsuzsa
Björnstedt, Mikael
Kiss, András
Funding for this research was provided by:
Hungarian Scientific Research Fund (OTKA 128881, NVKP_16_1-2016-0004)
Semmelweis Egyetem (EFOP-3.6.3-VEKOP-16-2017-00009)
Cancerfonden
Radiumhemmets Forskningsfonder
Karolinska Institutet
Article History
Received: 12 June 2020
Accepted: 30 June 2020
First Online: 12 July 2020
Compliance with Ethical Standards
:
: M.B. is listed as inventor in a patent application for i.v. use of inorganic Se in cancer patients and holds shares in SELEQ OY, a company involved in development of Se-based formulations for prevention and treatment.